Earlier this month, Apple Inc. launched MacBook and shook up the budget laptop market. The launch naturally raised questions about this product's impact on the market share of Alphabet Inc.'s Google Chromebooks and PCs that run Microsoft Corp's Windows operating system. Apple Enters The Budget Laptop Segment MacBook Neo is a 13-inch laptop priced at $599. It is available at $499 for students, maki...
Earlier this month, Apple Inc. launched MacBook and shook up the budget laptop market. The launch naturally raised questions about this product's impact on the market share of Alphabet Inc.'s Google Chromebooks and PCs that run Microsoft Corp's Windows operating system. Apple Enters The Budget Laptop Segment MacBook Neo is a 13-inch laptop priced at $599. It is available at $499 for students, making it especially appealing to students who want to become part of the Apple ecosystem but couldn’t b
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that, further to its news releases dated March 12, 2026 and March 13, 2026, it has closed the first tranche of its non-brokered private placement (the "Private Placement") raising $136,000 through the sale of 2,720,000 units (each, a "Uni...
Vancouver, British Columbia--(Newsfile Corp. - March 25, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that, further to its news releases dated March 12, 2026 and March 13, 2026, it has closed the first tranche of its non-brokered private placement (the "Private Placement") raising $136,000 through the sale of 2,720,000 units (each, a "Unit") at a price of $0.05 per Unit. Each Unit consists of one common share of the Company (each, a...
Reversal by London police comes as Shabana Mahmood prepares an appeal against high court overturning ban on the group The Metropolitan police has said it will resume arresting people who show support for Palestine Action just weeks after it said it would no longer do so following a high court ruling that the ban on the direct action group was unlawful. After last month’s judgment, the Met police s...
Reversal by London police comes as Shabana Mahmood prepares an appeal against high court overturning ban on the group The Metropolitan police has said it will resume arresting people who show support for Palestine Action just weeks after it said it would no longer do so following a high court ruling that the ban on the direct action group was unlawful. After last month’s judgment, the Met police said it would immediately stop arresting people for such offences under the Terrorism Act but would gather evidence for potential future prosecutions. Continue reading...
Beijing’s long-standing geopolitical playbook – stay in your lane, avoid military entanglement, prepare exhaustively and issue bland “win-win” statements about the UN charter and calls to talk not fight – could see China emerge favourably from the Iran war, said economists, analysts and former US officials, as the conflict enters its fourth week with little end in sight and the US barrelling ahead...
Beijing’s long-standing geopolitical playbook – stay in your lane, avoid military entanglement, prepare exhaustively and issue bland “win-win” statements about the UN charter and calls to talk not fight – could see China emerge favourably from the Iran war, said economists, analysts and former US officials, as the conflict enters its fourth week with little end in sight and the US barrelling ahead. “People always say that China doesn’t understand the Mideast,” said Jeremy Chan, senior analyst...
Japan’s run of struggling stock market debuts has stretched to the longest in six years, another sign of investor sentiment being shaken by the war in Iran. J-Pharma Co. dropped as much as 22% and Basic Inc. fell as much as 8% on their first day of trading, on a day when Japan’s stock benchmarks advanced along with the rest of Asia. Three other companies this year also fell at the open compared wi...
Japan’s run of struggling stock market debuts has stretched to the longest in six years, another sign of investor sentiment being shaken by the war in Iran. J-Pharma Co. dropped as much as 22% and Basic Inc. fell as much as 8% on their first day of trading, on a day when Japan’s stock benchmarks advanced along with the rest of Asia. Three other companies this year also fell at the open compared with their initial public offering prices. The last time more than five new shares sank on their debut was in March 2020. Japanese stocks had entered a technical correction this month as the war in Iran turned investors more risk averse. The same sentiment is amplified in the IPO market, with only seven deals priced so far this year, the fewest in any first quarter since 2011, according to Bloomberg-compiled data. “The sentiment is getting pretty bad,” said Takamasa Ikeda , a senior portfolio manager at GCI Asset Management Inc., who has stopped joining IPOs this month as buying newly listed shares in the secondary market looked more reasonable. Japan’s IPO market has been reshaped by banks turning to bigger deals and the Tokyo bourse raising the bar for companies to remain listed on its startup market section. That resulted in the number of tiny-sized deals decreasing to a 12-year low last year. Drugmaker ReqMed Scraps Tokyo IPO Plans on Market Volatility Flipping Japan IPOs Loses Luster as Small Share Sales Fade Japan’s Small IPOs Fall to 12-Year Low Amid Market Reforms
Baltimore Democrats Triggered After Grok Generates Bikini Elon Musk, Sue xAI Over Sexual Deepfakes The left-wing one-party rule in Baltimore City can barely govern its own imploding metro area . Parts of downtown are ghost towns; the resident exodus has been severe; taxes are through the roof; industry has left; and decades of progressive policies have helped transform large parts of the metro are...
Baltimore Democrats Triggered After Grok Generates Bikini Elon Musk, Sue xAI Over Sexual Deepfakes The left-wing one-party rule in Baltimore City can barely govern its own imploding metro area . Parts of downtown are ghost towns; the resident exodus has been severe; taxes are through the roof; industry has left; and decades of progressive policies have helped transform large parts of the metro area into crime-ridden no-go zones. Yet somehow, city officials still found the time to weaponize local agencies and go after Elon Musk. Baltimore Mayor Brandon M. Scott and the City Council of Baltimore, represented by the Baltimore City Law Department and DiCello Levitt, filed a lawsuit in the Circuit Court for Baltimore City against Elon Musk's xAI, claiming Grok users were able to create non-consensual sexual deepfakes, including images involving minors, and that the defendants violated Baltimore's Consumer Protection Ordinance. The core claim in the lawsuit is that Grok was marketed as a general-purpose AI chatbot with supposed safeguards, but in reality, it allegedly allowed users to "undress," sexualize, and manipulate photos of real people, including children, with minimal prompting and without meaningful guardrails or age verification. "Beginning in late 2025, x.AI expanded Grok's image-generation and image-editing features, which 'edit' existing photographs, including images of private individuals and children, into photorealistic, sexually explicit, or otherwise degrading content. These features allow Grok, with minimal prompting, to 'undress,' sexualize, or otherwise manipulate images uploaded by or depicting third parties," the lawsuit reads. The lawsuit claims xAI knew the chatbot could be abused on a large scale. It cites allegations that millions of sexualized images were generated in a short period, including thousands that appeared to depict children, and argues users in the metro area were exposed either to the content itself or to the risk that their own im...
Kurt M. Eckert, a director of Miami International Holdings (NYSE:MIAX) , reported the sale of 37,917 shares of common stock—via option exercise and immediate disposition—for a total of approximately $1.48 million, according to a SEC Form 4 filing covering March 19, 2026. Transaction value based on SEC Form 4 weighted average purchase price ($39.00); post-transaction value based on March 19, 2026 m...
Kurt M. Eckert, a director of Miami International Holdings (NYSE:MIAX) , reported the sale of 37,917 shares of common stock—via option exercise and immediate disposition—for a total of approximately $1.48 million, according to a SEC Form 4 filing covering March 19, 2026. Transaction value based on SEC Form 4 weighted average purchase price ($39.00); post-transaction value based on March 19, 2026 market close ($39.00). Miami International Holdings, Inc. is a diversified exchange operator with a growing presence in the U.S. and international capital markets. The company leverages a multi-asset platform strategy to attract volume and liquidity across options, equities, and futures products. Its integrated clearing and execution services, combined with a focus on technology, position it to compete effectively in the evolving financial marketplace. Continue reading
Sandwish/iStock via Getty Images SPY vs. JEPI: Current Valuation Gap and VIX Unlikely to Last My last work on the JPMorgan Equity Premium Income ETF ( JEPI ) was published on Dec 23, 2025, and rated the stock as a buy . The rating was mainly based on the consideration of the VIX index (which was relatively low at that time), the inflation data, and also JEPI’s valuation. Since the publication of t...
Sandwish/iStock via Getty Images SPY vs. JEPI: Current Valuation Gap and VIX Unlikely to Last My last work on the JPMorgan Equity Premium Income ETF ( JEPI ) was published on Dec 23, 2025, and rated the stock as a buy . The rating was mainly based on the consideration of the VIX index (which was relatively low at that time), the inflation data, and also JEPI’s valuation. Since the publication of that work, our macroeconomic conditions have undergone a few material changes, which motivated this reassessment of the return/risk calculus of JEPI relative to the broader market, for which I will use the SPDR S&P 500 ETF Trust ( SPY ) as a proxy. More specifically, the remainder of this article will examine 2 changes in detail: the changes in the VIX index and also the changes in their dividends. In the end, my overall conclusion is that the current market conditions present a compelling case for JEPI due to its high income and volatility-mitigating strategies. As a reflection of the ongoing volatility, both funds have suffered sharp price corrections since early March, as you can see from the next chart. Looking ahead, with the uncertainties evolving around inflation, interest rates, and also geological conflicts in the Middle East, I anticipate elevated VIX to persist. Under this outlook, JEPI offers a superior risk-adjusted profile for the current environment, especially for investors who need active income, as detailed next. Seeking Alpha JEPI and SPY: Basic Information Before diving in, let me quickly cover the basics of JEPI and SPY. The SPY ETF probably needs no introduction, and I will just quote the fund’s brief bio below. SPY Fund description: The fund tracks the massively popular US index, the S&P 500. The index offers outstanding exposure to the US large-cap space. JEPI needs a bit more of an introduction. The fund actively evaluates overvalued and undervalued stocks in the SP500 universe to construct its portfolio. In the meantime, the fund also actively sells...
Prologis CEO Dan Letter joins Bloomberg Businessweek Daily to discuss the state of global logistics and shipping as geopolitics and associated risk impacts the firm's customer base. However, Prologis is optimistic about its data center business. Letter says the company's strong relationship with hyperscalers is ongoing, bolstering "a fortress of a balance sheet" as Prologis continues to secure lon...
Prologis CEO Dan Letter joins Bloomberg Businessweek Daily to discuss the state of global logistics and shipping as geopolitics and associated risk impacts the firm's customer base. However, Prologis is optimistic about its data center business. Letter says the company's strong relationship with hyperscalers is ongoing, bolstering "a fortress of a balance sheet" as Prologis continues to secure longer-term power capacity. Letter speaks with Carol Massar and Tim Stenovec. (Source: Bloomberg)
Earnings Call Insights: Tivic Health Systems, Inc. (TIVC) Q4 2025 Management View Michael Handley, CEO, announced, "It is a privilege to address you for the first time as CEO of Tivic. I'm honored to lead the company at this transformative juncture. My focus is clear and resolute evolving Tivic into a high-impact immunotherapy company dedicated to saving lives, advancing critical therapies to pati...
Earnings Call Insights: Tivic Health Systems, Inc. (TIVC) Q4 2025 Management View Michael Handley, CEO, announced, "It is a privilege to address you for the first time as CEO of Tivic. I'm honored to lead the company at this transformative juncture. My focus is clear and resolute evolving Tivic into a high-impact immunotherapy company dedicated to saving lives, advancing critical therapies to patients and delivering significant long-term value to our shareholders." Handley highlighted the company’s full pivot into immunotherapy, now anchored by the TLR5 platform, with lead candidates Entolimod and Entolasta at the center of this new strategic direction. Handley stated the company completed its acquisition of in-house manufacturing capabilities and launched Velocity Bioworks, which is expected to offer both cost efficiencies for Tivic and a new revenue stream as a contract manufacturing organization. "By internalizing our manufacturing, we have already achieved substantial reduction in development time lines and costs for Entolimod. Additionally, we have controlled our own supply chain and are poised to scale Entolimod as needed." The CEO described the discontinuation of all non-core businesses, including the ClearUP device and neuromodulation programs, allowing Tivic to focus exclusively on biotherapeutics: "By shedding these legacy assets, we have concentrated 100% of our resources on high-value biotherapeutic opportunities." Handley outlined a strategic focus on the oncology supportive care market, referencing its estimated value of nearly $15 billion and expected growth to $20 billion by the 2030s. He emphasized that Tivic is "aggressively moving Entolimod into large market clinical indications, beginning with neutropenia," and targeting physician-sponsored trials within the year. The CEO also pointed to active engagement with U.S. government agencies for potential biodefense contracts: "We are actively engaged with BARDA, NIAID and the Department of Water to sec...
Rybakina completes 2-6, 6-3, 6-4 comeback win American slumps to fifth straight defeat to Kazakhstani Jessica Pegula had her chances. Midway through the second set of yet another enormous match with Elena Rybakina, the American had engineered a flawless start. After bulldozing through the opening set, Pegula’s level at the beginning of set two put her in with a fair shot of snatching a win against...
Rybakina completes 2-6, 6-3, 6-4 comeback win American slumps to fifth straight defeat to Kazakhstani Jessica Pegula had her chances. Midway through the second set of yet another enormous match with Elena Rybakina, the American had engineered a flawless start. After bulldozing through the opening set, Pegula’s level at the beginning of set two put her in with a fair shot of snatching a win against her Kazakhstani opponent, who has dominated their recent meetings. Instead, Pegula departed Miami with another tough lesson to parse through after being shown once again that the best players in the world pounce on even the smallest drops in intensity. Despite her mediocre start, Rybakina produced a brilliant comeback to reach the Miami Open semi-finals with a 2-6, 6-3, 6-4 win. Continue reading...
Constellation Energy (NASDAQ: CEG) provided a nice jolt to investors' portfolios in mid-week trading. On news that an influential investment bank resumed coverage of the stock with a bullish update on Wednesday, investors snapped up the shares, sending them up 3% that trading session. The person behind this was Morgan Stanley 's David Arcaro, who flagged Constellation stock as an overweight (read:...
Constellation Energy (NASDAQ: CEG) provided a nice jolt to investors' portfolios in mid-week trading. On news that an influential investment bank resumed coverage of the stock with a bullish update on Wednesday, investors snapped up the shares, sending them up 3% that trading session. The person behind this was Morgan Stanley 's David Arcaro, who flagged Constellation stock as an overweight (read: buy) at a $385 price target. That's 27% above its latest closing price. Image source: Getty Images. Continue reading
Sturm, Ruger & Company ( RGR ) said on Wednesday its board has received a letter from Beretta Holding S.A. proposing a partial tender offer for up to 20.05% of its outstanding shares. The company said the proposed offer, which has not yet commenced, could raise Beretta’s ownership stake in Ruger to about 30% if completed. Ruger said its board will review the proposal with advisers and respond in d...
Sturm, Ruger & Company ( RGR ) said on Wednesday its board has received a letter from Beretta Holding S.A. proposing a partial tender offer for up to 20.05% of its outstanding shares. The company said the proposed offer, which has not yet commenced, could raise Beretta’s ownership stake in Ruger to about 30% if completed. Ruger said its board will review the proposal with advisers and respond in due course, adding that shareholders do not need to take any action at this time. Source: Press Release More on Sturm, Ruger Sturm, Ruger & Company: New Platforms And Entry Into The Accessory Business Sturm, Ruger & Company, Inc. (RGR) Q4 2025 Earnings Call Transcript Sturm, Ruger & Company: 'In And Out' Is One Way To Play This One In 2026 Beretta offers to boost its stake in Sturm, Ruger by another 20% with a tender offer Firearms face-off: Sturm, Ruger and Beretta scrap over board seats